Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYMyriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate CancerPREV STORYCyclacel Pharmaceuticals to Release Second Quarter 2019 Financial Results